Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2002 | 1 |
2006 | 1 |
2007 | 1 |
2009 | 1 |
2011 | 1 |
2012 | 2 |
2015 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Three months of rifapentine and isoniazid for latent tuberculosis infection.
N Engl J Med. 2011 Dec 8;365(23):2155-66. doi: 10.1056/NEJMoa1104875.
N Engl J Med. 2011.
PMID: 22150035
Free article.
Clinical Trial.
Effect of HIV infection on tolerability and bacteriologic outcomes of tuberculosis treatment.
Bliven-Sizemore EE, Johnson JL, Goldberg S, Burman WJ, Villarino ME, Chaisson RE; Tuberculosis Clinical Trials Consortium.
Bliven-Sizemore EE, et al.
Int J Tuberc Lung Dis. 2012 Apr;16(4):473-9. doi: 10.5588/ijtld.11.0548.
Int J Tuberc Lung Dis. 2012.
PMID: 22325844
Clinical Trial.
Item in Clipboard
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosis.
Dorman SE, Johnson JL, Goldberg S, Muzanye G, Padayatchi N, Bozeman L, Heilig CM, Bernardo J, Choudhri S, Grosset JH, Guy E, Guyadeen P, Leus MC, Maltas G, Menzies D, Nuermberger EL, Villarino M, Vernon A, Chaisson RE; Tuberculosis Trials Consortium.
Dorman SE, et al.
Am J Respir Crit Care Med. 2009 Aug 1;180(3):273-80. doi: 10.1164/rccm.200901-0078OC. Epub 2009 Apr 30.
Am J Respir Crit Care Med. 2009.
PMID: 19406981
Clinical Trial.
Item in Clipboard
Three months of weekly rifapentine plus isoniazid is less hepatotoxic than nine months of daily isoniazid for LTBI.
Bliven-Sizemore EE, Sterling TR, Shang N, Benator D, Schwartzman K, Reves R, Drobeniuc J, Bock N, Villarino ME; TB Trials Consortium.
Bliven-Sizemore EE, et al.
Int J Tuberc Lung Dis. 2015 Sep;19(9):1039-44, i-v. doi: 10.5588/ijtld.14.0829.
Int J Tuberc Lung Dis. 2015.
PMID: 26260821
Free PMC article.
Clinical Trial.
Item in Clipboard
A prospective, randomized, double-blind study of the tolerability of rifapentine 600, 900, and 1,200 mg plus isoniazid in the continuation phase of tuberculosis treatment.
Bock NN, Sterling TR, Hamilton CD, Pachucki C, Wang YC, Conwell DS, Mosher A, Samuels M, Vernon A; Tuberculosis Trials Consortium, Centers for Disease Control and Prevention, Atlanta, Georgia.
Bock NN, et al. Among authors: conwell ds.
Am J Respir Crit Care Med. 2002 Jun 1;165(11):1526-30. doi: 10.1164/rccm.200201-047OC.
Am J Respir Crit Care Med. 2002.
PMID: 12045127
Clinical Trial.
Item in Clipboard
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortium.
Dorman SE, Goldberg S, Stout JE, Muzanyi G, Johnson JL, Weiner M, Bozeman L, Heilig CM, Feng PJ, Moro R, Narita M, Nahid P, Ray S, Bates E, Haile B, Nuermberger EL, Vernon A, Schluger NW; Tuberculosis Trials Consortium.
Dorman SE, et al.
J Infect Dis. 2012 Oct 1;206(7):1030-40. doi: 10.1093/infdis/jis461. Epub 2012 Jul 30.
J Infect Dis. 2012.
PMID: 22850121
Clinical Trial.
Item in Clipboard
Factors associated with loss to follow-up in a large tuberculosis treatment trial (TBTC Study 22).
Conwell DS, Mosher A, Khan A, Tapy J, Sandman L, Vernon A, Horsburgh CR Jr.
Conwell DS, et al.
Contemp Clin Trials. 2007 May;28(3):288-94. doi: 10.1016/j.cct.2006.09.003. Epub 2006 Sep 28.
Contemp Clin Trials. 2007.
PMID: 17107825
Item in Clipboard
Cite
Cite